Search Results - "Trinchet, JC"

Refine Results
  1. 1

    UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers? by Stücker, I, Loriot, M A, N'koutchou, G, Cénée, S, Bodin, L, Mulot, C, Gelu-Simeon, M, Pelletier, L, Bronowicki, J P, Degos, F, Beaune, P, Laurent-Puig, P, Hémon, D, Trinchet, J C, Pelletier, G

    Published in BMC cancer (19-11-2007)
    “…We conducted a case-control study to evaluate the role of UDP-glucuronosyltransferase 1A7 (UGT1A7) polymorphisms in the onset of hepatocellular carcinoma…”
    Get full text
    Journal Article
  2. 2

    Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C by ZIOL, Marianne, HANDRA-LUCA, Adriana, BEAUGRAND, Michel, KETTANEH, Adrien, CHRISTIDIS, Christos, MAL, Frédéric, KAZEMI, Farhad, DE LEDINGHEN, Victor, MARCELLIN, Patrick, DHUMEAUX, Daniel, TRINCHET, Jean-Claude

    Published in Hepatology (Baltimore, Md.) (2005)
    “…Liver fibrosis is the main predictor of the progression of chronic hepatitis C, and its assessment by liver biopsy (LB) can help determine therapy. However,…”
    Get full text
    Journal Article
  3. 3

    Ursodeoxycholic acid for primary sclerosing cholangitis by Chazouillères, O, Poupon, R, Capron, J P, Metman, E H, Dhumeaux, D, Amouretti, M, Couzigou, P, Labayle, D, Trinchet, J C

    Published in Journal of hepatology (01-07-1990)
    “…The effects of ursodeoxycholic acid (UDCA, 750-1250 mg/day) were evaluated prospectively in 15 patients with primary sclerosing cholangitis (PSC). Five…”
    Get more information
    Journal Article
  4. 4

    A new prognostic classification for predicting survival in patients with hepatocellular carcinoma by Chevret, Sylvie, Trinchet, Jean-Claude, Mathieu, Didier, Rached, Antoine Abou, Beaugrand, Michel, Chastang, Claude

    Published in Journal of hepatology (01-07-1999)
    “…Background/Aims: In patients with hepatocellular carcinoma, prediction of survival is difficult. The aim of this prospective study was to provide a simple…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death by Degos, F, Christidis, C, Ganne-Carrie, N, Farmachidi, J-P, Degott, C, Guettier, C, Trinchet, J-C, Beaugrand, M, Chevret, S

    Published in Gut (01-07-2000)
    “…BACKGROUND In patients with hepatitis C virus (HCV) infection and cirrhosis, long term outcome and the incidence of hepatocellular carcinoma (HCC) are still…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Local/regional and systemic treatments of hepatocellular carcinoma by Beaugrand, Michel, N'kontchou, Giselè, Seror, Olivier, Ganne, Nathalie, Trinchet, Jean-Claude

    Published in Seminars in liver disease (01-05-2005)
    “…Screening programs for patients with cirrhosis are designed to detect hepatocellular carcinoma at an early stage when effective treatment is feasible and may…”
    Get more information
    Journal Article
  9. 9

    A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular Carcinoma by TRINCHET, J.-C

    Published in The New England journal of medicine (11-05-1995)
    “…The efficacy of therapies for hepatocellular carcinoma is poor. 1 , 2 Hepatocellular carcinoma is a hypervascular tumor. 3 Hepatic intraarterial injection of…”
    Get full text
    Journal Article
  10. 10

    Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis by Ziol, Marianne, Tepper, Maryline, Lohez, Manuel, Arcangeli, Gilles, Ganne, Nathalie, Christidis, Christos, Trinchet, Jean-Claude, Beaugrand, Michel, Guillet, Jean-Gérard, Guettier, Catherine

    Published in Journal of hepatology (01-02-2001)
    “…Background/Aims : Although human and experimental studies have shown that apoptosis plays a role in hepatocyte death in alcoholic liver disease, its clinical…”
    Get full text
    Journal Article
  11. 11

    Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen by Trinchet, Jean–Claude

    Published in Hepatology (Baltimore, Md.) (01-12-2004)
    “…The growth of hepatocellular carcinoma (HCC) is thought to be dependent on androgens, as androgen receptors are present in most of these tumors. The aim of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study by Ganne-Carrié, N, Christidis, C, Chastang, C, Ziol, M, Chapel, F, Imbert-Bismut, F, Trinchet, J-C, Guettier, C, Beaugrand, M

    Published in Gut (01-02-2000)
    “…BACKGROUND/AIMS A study was undertaken of liver biopsy samples from 229 consecutive patients with alcoholic or hepatitis C virus related cirrhosis who were…”
    Get full text
    Journal Article
  14. 14

    Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions by Christidis, Christos, Mal, Frédéric, Ramos, Jeanne, Senejoux, Agnès, Callard, Patrice, Navarro, Robert, Trinchet, Jean-Claude, Larrey, Dominique, Beaugrand, Michel, Guettier, Catherine

    Published in Journal of hepatology (01-12-2001)
    “…Background/Aims : Due to its apparent safety and low cost, hydroxyethylstarch (HES) is increasingly used as a volume expander. The aim of this retrospective…”
    Get full text
    Journal Article
  15. 15

    Ursodiol for the Long-Term Treatment of Primary Biliary Cirrhosis by Poupon, Raoul, Poupon, Renee E, Balkau, Beverley

    Published in The New England journal of medicine (12-05-1994)
    “…Primary biliary cirrhosis is a chronic cholestatic liver disease that progresses slowly toward a terminal phase characterized by hyperbilirubinemia, signs of…”
    Get full text
    Journal Article
  16. 16

    Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis by Ganne‐Carrie, N, Chastang, C, Chapel, F, Munz, C, Pateron, D, Sibony, M, Deny, P, Trinchet, J, Callard, P, Guettier, C, Beaugrand, M

    Published in Hepatology (Baltimore, Md.) (01-05-1996)
    “…The aim of this study was to identify high‐risk patients for hepatocellular carcinoma (HCC). Among 151 patients with histologically proven cirrhosis…”
    Get full text
    Journal Article
  17. 17

    Radiofrequency ablation for the treatment of liver tumors in the caudate lobe by Seror, Olivier, Haddar, Djamel, N'Kontchou, Gisèle, Ajavon, Yves, Trinchet, Jean-Claude, Beaugrand, Michel, Sellier, Nicolas

    “…To evaluate the effectiveness of radiofrequency (RF) ablation for liver tumors located in the caudate lobe. Ten patients (46-79 years of age; median, 70 y),…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease by Haddad, J, Deny, P, Munz-Gotheil, C, Ambrosini, J C, Trinchet, J C, Pateron, D, Mal, F, Callard, P, Beaugrand, M

    Published in The Lancet (British edition) (08-02-1992)
    “…Viral infection has often been suggested as a possible cause of Sjögren's syndrome or chronic lymphocytic sialadenitis, and Epstein-Barr virus has been found…”
    Get more information
    Journal Article
  20. 20

    Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis by Pateron, D, Ganne, N, Trinchet, J C, Aurousseau, M H, Mal, F, Meicler, C, Coderc, E, Reboullet, P, Beaugrand, M

    Published in Journal of hepatology (01-01-1994)
    “…Screening is widely used to detect early hepatocellular carcinoma in Asian patients with cirrhosis. Its effectiveness in Caucasian patients has been suggested,…”
    Get more information
    Journal Article